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The formation of a right atrial mass was detected in a 
patient by two-dimensional echocardiography 3 weeks 
after successful transvenous electrical ablation of the 
atrioventricular node had been performed. The mass 
was attached to the atrial septum at the site where the 
electrode catheter used for the ablation had supposedly 
been located and it exhibited no mobility. It was inter-
Transvenous catheter ablation of the atrioventricular (A V) 
node is an effective treatment for selected patients with 
various types of drug-resistant supraventricular arrhythmias. 
Complications have been observed in only a small number 
of patients (1-3). We report on the formation of a right 
atrial thrombus at the site where the A V node had been 
successfully ablated by this technique. 
Case Report 
Patient data. A 25 year old woman was referred to our 
hospital because of recurrent drug-resistant tachycardia with 
a wide QRS complex and a heart rate of 240 beats/min, 
which had been leading to cardiovascular collapse during 
the last five episodes. The patient had been treated unsuc•
cessfully with seven conventional and five investigational 
antiarrhythmic drugs, including amiodarone. She had no 
history of peripheral venous thrombosis and had never taken 
drugs predisposing to a hypercoagulable state. Physical ex•
amination revealed no abnormalities. Routine laboratory tests 
including blood coagulation analysis, two-dimensional 
echocardiogram (Fig. l) and chest X-ray film were normal. 
The 12 lead electrocardiogram showed a regular sinus rhythm 
at a heart rate of 76 beats/min with narrow QRS complexes 
and a normal PQ interval. 
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preted as a right atrial thrombus induced by the ablation 
procedure. Although no pulmonary embolic events have 
been observed during a 7 month follow-up period, right 
atrial thromboembolism must be considered a poten•
tially dangerous complication of transvenous catheter 
ablation to control cardiac arrhythmias. 
(J Am Coil CardioI1985;6:1428-30) 
Electrophysiologic evaluation in a drug-free state, using 
previously described techniques (4), disclosed that the pa•
tient had A V nodal reciprocating tachycardia with functional 
right bundle branch block. During episodes of tachycardia 
the patient complained of dizziness and presyncope. Be•
cause of the previous failure of antiarrhythmic drug treat•
ment to control the tachycardia, no further drug testing was 
performed during the electrophysiologic study. 
Ablation procedure. After informed written consent had 
been obtained from the patient, she underwent transvenous 
catheter ablation of the A V node according to the technique 
described by Gallagher et al. (2) in a second procedure. 
After positioning of electrode catheters in the right ventricle, 
high right atrium and low right atrium at the region of the 
A V node, a bolus of 100 units/kg body weight of heparin 
was given intravenously, followed by an infusion of 1,000 
units/h for 12 hours. Using a standard 6F tripolar (USCI) 
pacing electrode, two direct current shocks of 200 and 300 
J were delivered to the A V node 30 minutes apart. This 
resulted in complete A V nodal block with a regular escape 
rhythm at a rate of 38 beats/min and right bundle branch 
block-shaped QRS complexes. Two hours after the proce•
dure no type of tachycardia was inducible. 
On the following day a DDD pacemaker was implanted 
uneventfully. The patient then received low dose heparin 
(100 units/kg twice daily) subcutaneously for the next 7 
days until she was fully mobilized. Blood coagulation tests 
showed no prolongation of thrombin time with this dosage. 
On the eighth day after trans venous catheter ablation she 
was discharged. 
Follow-up. At the first control visit 2 weeks after the 
procedure the patient reported no recurrences of tachycardia. 
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Figure 1. Two-dimensional echocardiogram in the parasternal short•
axis view at the level of Ihe aortic valve, taken before trans venous 
catheter ablation of the atrioventricular node. Atrial cavities are 
echo-free. Ao = aorta; LA = left atrium; RA = right atrium. 
Physical examination showed no deviation from the first 
presentation. The 12 lead electrocardiogram showed only 
pacemaker-induced ventricular depolarizations, synchro•
nized to atrial events. 
Two-dimensional echocardiography. On the two•
dimensional echocardiogram a strongly echogenic, oval•
shaped mass about 25 mm long was detected in the low 
right anterior region of the atrial septum, suggesting the 
formation of a thrombus within the right atrium (Fig. 2). 
The mass appeared to be firmly attached to the atrial septum, 
from which it could be clearly differentiated in various echo•
cardiographic views because of its higher echogenicity. It 
exhibited no mobility during the cardiac cycle, thereby caus-
Figure 2. Two-dimensional echocardiogram of the same patient 
as in Figure I, taken 3 weeks after trans venous catheter ablation 
of the atrioventricular node. The orientation of the image is the 
same as in Figure I. A highly echogenic right atrial mass (Th), 
attached by a broad base to the atrial septum, is clearly visualized. 
Note disappearance of posteromedial portion of atrial septal echo 
(arrow) because of acoustic shadowing due to thrombus. Abbre•
viations as in Figure I. 
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ing no impedance to right ventricular inflow. This structure 
had not been observed on the two-dimensional echocardio•
gram before trans venous catheter ablation (Fig. I). 
By injection of indium-J J J -labeled platelets, an attempt 
was made to assess the thrombogenic activity of the throm•
bus surface using sequential indium-III scintigraphy (5). 
There was, however, no evidence of new platelet apposition 
at that time. The patient was discharged on a daily oral dose 
of 330 mg of acetylsalicyclic acid in combination with 225 
mg of dipyridamole as prophylaxis against thromboembolic 
complications. 
During further control visits every 4 weeks the echocar•
diographic appearance of the right atrial mass remained 
unchanged and there were neither clinical nor scintigraphic 
signs of pulmonary embolism. Electrocardiographic con•
trols with the DDD pacemaker in the "off" mode still 
revealed complete A V conduction block and a slow ven•
tricular escape rhythm. After 7 months the patient's follow•
up course has been uneventful without recurrences of 
tachycardia. 
Discussion 
In the treatment of certain drug-resistant supraventricular 
tachyarrhythmias, transvenous catheter ablation of the A V 
node is considered to be an effective therapeutic measure. 
However, serious complications have been observed either 
immediately after the procedure or during early follow-up 
(3). The complication of thrombus formation after trans•
venous catheter ablation has not yet been reported. In our 
patient a right atrial mass was detected by two-dimensional 
echocardiography 3 weeks after transvenous catheter abla•
tion of the A V node. This mass had not been present on 
the same echocardiographic views before trans venous cath•
eter ablation. It originated low anteriorly at the right atrial 
septum, that is, precisely where the electrode catheter used 
for ablation had been located during the procedure. 
Differential diagnosis of right atrial masses. The mass 
was assumed to represent a thrombus as a consequence of 
direct current application to atrial tissue rather than a ma•
lignant tumor, atrial myxoma or tricuspid valve vegetation 
(6). A malignant tumor or atrial myxoma represents a chronic 
condition and should therefore have been detected before 
transvenous catheter ablation. A tricuspid valve vegetation 
is highly unlikely because of the lack of mobility of the 
mass in concert with valve leaflet motion. Thrombus for•
mation as a consequence of electrical current application 
has been reported in animal experiments (7). 
Tissue changes after electrical ablation. Histologic 
studies in dogs undergoing transvenous ablation of A V con•
duction have shown mild fibrous reaction at the base of the 
septal tricuspid leaflet in those dogs that had chronic com•
plete heart block after the shocks (8). 
In a patient who died 5.5 months after transvenous A V 
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node ablation by a single shock of 275 J (9), microscopic 
examination of the endocardium overlying the A V node was 
normal, and no inflammatory cells were present (9). In 
another patient, who died suddenly 5.5 weeks after trans•
venous catheter ablation of the A V node by two shocks of 
500 J each (I), there was no evidence at necropsy of intra•
cardiac clots and no gross evidence of myocardial damage 
in the region where the shocks had been delivered. 
Macroscopic or microscopic findings with regard to en•
docardial changes provoking thrombus formation as a con•
sequence of transvenous catheter ablation have not been 
described. Because of the lack of other thrombogenic factors 
in our case, the application of two shocks of standard energy 
levels to the region of the A V node had probably resulted 
in endocardial damage extensive enough to lead to local 
thrombus formation. 
Sequelae of right atrial masses. Thrombus formation 
within the right atrium may lead to pulmonary embolism 
(6,10). How often emboli originate in the right atrium of 
patients with pulmonary embolism is not definitely known, 
but it is considered rare (6, II). In our patient there was no 
evidence that the thrombus gave rise to pulmonary com•
plications and neither surgical intervention nor thrombolytic 
therapy was required. However, the outcome of patients 
with a right atrial thrombus may be fatal, especially if the 
thrombus is mobile, and physicians performing transvenous 
catheter ablation should be well aware of this risk. 
Clinical implications. We suggest that patients 
undergoing transvenous catheter ablation of the A V node 
should undergo anticoagulation with antiplatelet drugs for 
4 weeks after low dose heparinization. After that period the 
endocardial surface is expected to have healed. We rec•
ommend the combined antiplatelet treatment with dipy•
ridamole and acetylsalicyclic acid rather than treatment with 
warfarin (Coumadin), because this combination has been 
shown to prevent thrombus formation in animal experiments 
(12) and has less potential for bleeding complications (13). 
Two-dimensional echocardiograms should be performed re•
petitively after trans venous catheter ablation to detect the 
potentially hazardous formation of right atrial thrombi, ne•
cessitating further diagnostic and therapeutic interventions. 
Our observation indicates that, because of the relatively 
short duration of use and the lack of long-term follow-up 
data, unexpected complications of transvenous catheter 
ablation may still occur. Therefore, the technique should be 
applied with caution and only after other methods have 
failed. 
COI~c1usions. To our knowledge, this is the first case of 
thrombus formation after transvenous catheter ablation of 
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the A V node. Because there were no mitigating factors in 
our patient that might cause a hypercoagulable state, we 
believe that thrombus formation as a consequence of trans•
venous catheter ablation may not be an isolated incidence 
but may be a complication of transvenous catheter ablation 
that has hitherto not been recognized because it has not been 
looked for systematically. 
We are indebted to Volker Siglow for assistance with the echocardiographic 
studies. 
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